Impact of self-reported fasting duration on lipid profile variability, cardiovascular risk stratification and metabolic syndrome diagnosis (2018)
- Authors:
- USP affiliated authors: BITTENCOURT, MÁRCIO SOMMER - HU ; SANTOS FILHO, RAUL DIAS DOS - FM
- Unidades: HU; FM
- DOI: 10.20945/2359-3997000000023
- Subjects: DOENÇAS CARDIOVASCULARES; JEJUM
- Keywords: TRIGLYCERIDES; CARDIOVASCULAR RISK; METABOLIC SYNDROME
- Language: Inglês
- Imprenta:
- Publisher: Sociedade Brasileira de Endocrinologia e Metabologia
- Publisher place: São Paulo
- Date published: 2018
- Source:
- Título do periódico: Archives of Endocrinology and Metabolism
- ISSN: 2359-3997
- Volume/Número/Paginação/Ano: v. 62, n. 2, p. 187-192, apr. 2018
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
JANOVSKY, Carolina Castro Porto Silva; LAURINAVICIUS, Antonio; CASENA, Fernando; et al. Impact of self-reported fasting duration on lipid profile variability, cardiovascular risk stratification and metabolic syndrome diagnosis. Archives of Endocrinology and Metabolism, São Paulo, Sociedade Brasileira de Endocrinologia e Metabologia, v. 62, n. 2, p. 187-192, 2018. Disponível em: < http://www.scielo.br/pdf/aem/v62n2/2359-3997-aem-2359-3997000000023.pdf > DOI: 10.20945/2359-3997000000023. -
APA
Janovsky, C. C. P. S., Laurinavicius, A., Casena, F., Valente, V., Ferreira, C. E., Mangueira, C., et al. (2018). Impact of self-reported fasting duration on lipid profile variability, cardiovascular risk stratification and metabolic syndrome diagnosis. Archives of Endocrinology and Metabolism, 62( 2), 187-192. doi:10.20945/2359-3997000000023 -
NLM
Janovsky CCPS, Laurinavicius A, Casena F, Valente V, Ferreira CE, Mangueira C, Conceição R, Santos RD, Bittencourt MS. Impact of self-reported fasting duration on lipid profile variability, cardiovascular risk stratification and metabolic syndrome diagnosis [Internet]. Archives of Endocrinology and Metabolism. 2018 ; 62( 2): 187-192.Available from: http://www.scielo.br/pdf/aem/v62n2/2359-3997-aem-2359-3997000000023.pdf -
Vancouver
Janovsky CCPS, Laurinavicius A, Casena F, Valente V, Ferreira CE, Mangueira C, Conceição R, Santos RD, Bittencourt MS. Impact of self-reported fasting duration on lipid profile variability, cardiovascular risk stratification and metabolic syndrome diagnosis [Internet]. Archives of Endocrinology and Metabolism. 2018 ; 62( 2): 187-192.Available from: http://www.scielo.br/pdf/aem/v62n2/2359-3997-aem-2359-3997000000023.pdf - The expected cardiovascular benefit of plasma cholesterol lowering with or without LDL-C targets in healthy individuals at higher cardiovascular risk
- Association between Thyroid-Stimulating Hormone Levels and Non-Alcoholic Fatty Liver Disease Is Not Independent from Metabolic Syndrome Criteria
- Achilles tendon xanthomas are associated with the presence and burden of subclinical coronary atherosclerosis in heterozygous familial hypercholesterolemia: A pilot study
- Comparing the expected benefit of plasma cholesterol reduction with or without LDL-C targets in a high-risk, healthy population
- The obesity paradox on the treadmill: relationship between body mass index and positive exercise stress tests
- Cardiovascular risk stratification and statin eligibility based on the Brazilian vs. North American Guidelines on blood cholesterol management
- Association between clinical factors and self-underestimation of cardiovascular risk in subjects submitted to a routine health evaluation
- Low-density lipoprotein cholesterol goal achievement in patients with familial hypercholesterolemia in countries outside Western Europe: the International ChoLesterol management Practice Study
- Absence of coronary artery calcification and low rates not only of coronary and cardiovascular mortality [Editorial]: can the power of zero be expanded beyond the vessels?
- The selective peroxisome proliferator-activated receptor alpha modulator (SPPARM) paradigm: conceptual framework and therapeutic potential: A consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation
Informações sobre o DOI: 10.20945/2359-3997000000023 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
